Marc Hazzan

Summary

Country: France

Publications

  1. pmc Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients
    Marc Hazzan
    Service de Nephrologie, CHRU de Lille, Hopital Claude Huriez, Bd M Polonovski, 59000, Lille, France
    J Am Soc Nephrol 22:1375-81. 2011
  2. doi request reprint CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation
    Francois Glowacki
    EA4483, Faculte de Medecine, Pole Recherche, Lille, France
    Nephrol Dial Transplant 26:3046-50. 2011
  3. doi request reprint Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients
    Francois Glowacki
    Equipe d accueil 4483, Faculte de Medecine, Pole Recherche, Lille, France
    Clin Pharmacokinet 50:451-9. 2011
  4. ncbi request reprint Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil
    Marc Hazzan
    Clinique de Néphrologie, Hopital Calmette, CHRU de Lille, boulevard du Pr Leclercq, 59037, Lille, France
    Transpl Int 17:525-30. 2004
  5. pmc Increased circulating miR-21 levels are associated with kidney fibrosis
    Francois Glowacki
    EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine H Warembourg, Pole Recherche, Lille, France
    PLoS ONE 8:e58014. 2013
  6. pmc Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients
    Christian Noel
    Service de Nephrologie, Hopital Calmette, Lille, France
    J Am Soc Nephrol 20:1385-92. 2009
  7. ncbi request reprint HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells
    Abdelmejid Kandoussi
    Département de Recherches sur les Lipoprotéines et l Athérosclérose, INSERM U545, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019, Lille, France
    Clin Sci (Lond) 103:81S-83S. 2002

Collaborators

Detail Information

Publications7

  1. pmc Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients
    Marc Hazzan
    Service de Nephrologie, CHRU de Lille, Hopital Claude Huriez, Bd M Polonovski, 59000, Lille, France
    J Am Soc Nephrol 22:1375-81. 2011
    ..49; 95% confidence interval 1.02 to 19.9). Collectively, these data demonstrate that changes consistent with EMT are strong prognostic biomarkers in renal transplant recipients exposed to CsA...
  2. doi request reprint CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation
    Francois Glowacki
    EA4483, Faculte de Medecine, Pole Recherche, Lille, France
    Nephrol Dial Transplant 26:3046-50. 2011
    ....
  3. doi request reprint Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients
    Francois Glowacki
    Equipe d accueil 4483, Faculte de Medecine, Pole Recherche, Lille, France
    Clin Pharmacokinet 50:451-9. 2011
    ....
  4. ncbi request reprint Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil
    Marc Hazzan
    Clinique de Néphrologie, Hopital Calmette, CHRU de Lille, boulevard du Pr Leclercq, 59037, Lille, France
    Transpl Int 17:525-30. 2004
    ..In conclusion, mycophenolate mofetil is not only able to reduce the incidence of acute rejection but could also improve the prognostic significance of acute rejection crises...
  5. pmc Increased circulating miR-21 levels are associated with kidney fibrosis
    Francois Glowacki
    EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine H Warembourg, Pole Recherche, Lille, France
    PLoS ONE 8:e58014. 2013
    ..398, p = 0.006). Altogether, these data suggest miR-21 has a key pathogenic role in kidney fibrosis and may represent a novel, predictive and reliable blood marker of kidney fibrosis...
  6. pmc Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients
    Christian Noel
    Service de Nephrologie, Hopital Calmette, Lille, France
    J Am Soc Nephrol 20:1385-92. 2009
    ....
  7. ncbi request reprint HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells
    Abdelmejid Kandoussi
    Département de Recherches sur les Lipoprotéines et l Athérosclérose, INSERM U545, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019, Lille, France
    Clin Sci (Lond) 103:81S-83S. 2002
    ..Furthermore, we suggest that the mevalonate metabolism would interfere with PPAR-alpha activity...